Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Sino-Israel Bio-Industry Investment Fund 2
Guangzhou, Guangdong, China
- Ownership
- Private
- Development stage
- Other
01
Overview
GIBF2 is an investment fund that focuses on Western biotechnology companies developing innovative drugs in Phase 2-3 clinical trials. The fund has made strategic investments in companies developing treatments for cancer, antibiotic resistance, dermatological diseases, and food allergies. It partners with companies from Israel, Europe, and the United States to establish joint ventures in the Chinese market, providing comprehensive support including clinical trials, NMPA submission, commercialization, and manufacturing capacity development.
- Therapeutic areas
- OncologyInfectious DiseasesDermatology
- Modalities
- Monoclonal AntibodyAntibody-Drug ConjugateSmall MoleculeAntibacterial Agent
- Industry
- Investors
02
Partnerships
Guangzhou Development DistrictGovernment of Guangzhou
Beyond the preview
Go deeper on Guangzhou Sino-Israel Bio-Industry Investment Fund 2.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Sino-Israel Bio-Industry Investment Fund 2.